Portal de investigación
ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Martin Broto, Javier
- Moura, David
- Ramos, Rafael
- Martinez-Trufero, Javier
- Carrasco-Garcia, Irene
- Lopez-Pousa, Antonio
- Gonzalez-Billalabeitia, Enrique
- Cruz Jurado, Josefina
- Sebio, Ana
- Herrero Heras, Ana
- Valverde Morales, Claudia Maria
- Hindi, Nadia
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Martin,J,Diaz,R,Moura,D,Ramos,R,Martinez,J,Carrasco,I,Lopez,A et al. ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). 2023. Chicago. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2023.